Statement Of Financial Position [Abstract]

BioArctic - Filing #5863027

Concept	As at 2024-12-31	As at 2024-12-31	As at 2024-12-31	As at 2024-12-31	As at 2024-12-31	As at 2024-01-01	As at 2023-12-31	As at 2023-12-31	As at 2023-12-31	As at 2023-12-31	As at 2023-12-31	As at 2023-01-01	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31
Statement of financial position [abstract]
Assets [abstract]
Property, plant and equipment	—	—	—	39 451 SEK	—	—	—	—	—	23 536 SEK	—	—	—	—	—	—	—
Right-of-use assets	—	—	—	57 169 SEK	—	—	—	—	—	7 590 SEK	—	—	—	—	—	—	—
Deferred tax assets	—	—	—	957,000 SEK	—	—	—	—	—	566,000 SEK	—	—	—	—	—	—	—
Cash and cash equivalents	—	—	—	512 927 SEK	—	611 567 SEK	—	—	—	611 567 SEK	—	805 386 SEK	—	—	—	—	—
Assets	—	—	—	1 111 681 SEK	—	—	—	—	—	1 186 078 SEK	—	—	—	—	—	—	—
Equity and liabilities [abstract]
Equity [abstract]
Issued capital	—	—	—	1 768 SEK	—	—	—	—	—	1 766 SEK	—	—	—	—	—	—	—
Retained earnings	—	—	—	305 113 SEK	—	—	—	—	—	462 872 SEK	—	—	—	—	—	—	—
Share premium	—	—	—	587 103 SEK	—	—	—	—	—	580 979 SEK	—	—	—	—	—	—	—
Other reserves	—	—	—	958,000 SEK	—	—	—	—	—	958,000 SEK	—	—	—	—	—	—	—
Equity attributable to owners of parent	—	—	—	894 942 SEK	—	—	—	—	—	1 046 575 SEK	—	—	—	—	—	—	—
Equity	305 113 SEK	587 103 SEK	958,000 SEK	894 942 SEK	1 768 SEK	—	580 979 SEK	1 766 SEK	462 872 SEK	1 046 575 SEK	958,000 SEK	—	786 241 SEK	566 001 SEK	1 763 SEK	217 520 SEK	958,000 SEK
Liabilities [abstract]
Deferred tax liabilities	—	—	—	- SEK	—	—	—	—	—	12 385 SEK	—	—	—	—	—	—	—
Equity and liabilities	—	—	—	1 111 681 SEK	—	—	—	—	—	1 186 078 SEK	—	—	—	—	—	—	—